AASM releases statement on medical cannabis as treatment for obstructive sleep apnea

April 20, 2018

The American Academy of Sleep Medicine (AASM) recently released a position statement on medical cannabis use in the treatment of obstructive sleep apnea (OSA).  The AASM stated that medical cannabis should not used to treat OSA “due to unreliable delivery methods and insufficient evidence” that the treatment is effective and safe for patients with OSA; additionally, use can have significant side effects, which may include daytime sleepiness.  At least one state, Minnesota, has included OSA on its list of medical conditions for medical cannabis use; however, the AASM has stated that OSA should not be included on these lists and that further research is needed into the long-term viability of cannabis as a treatment for OSA before it is recommended as a treatment option.

Patients should always discuss treatment options with their physician prior to beginning any type of treatment.